SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

BRIEF-Health Canada Approves New Indication For Lung Cancer Treatment Option Alunbrig®

· 03/17/2021 08:32
BRIEF-Health Canada Approves New Indication For Lung Cancer Treatment Option Alunbrig®

- Takeda Pharmaceutical Co Ltd 4502.T:

  • HEALTH CANADA APPROVES NEW INDICATION FOR LUNG CANCER TREATMENT OPTION ALUNBRIG®

  • TAKEDA CANADA INC. - HEALTH CANADA HAS ISSUED ALUNBRIG(BRIGATINIB TABLETS) MARKETING AUTHORIZATION WITHOUT CONDITIONS

Source text for Eikon: ID:nCNWnFXsBa

Further company coverage: 4502.T


((Reuters.Briefs@thomsonreuters.com;))